References
- Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P. Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid 2010;17:101–104.
- den Dunnen JT, Antonarakis SE. Nomenclature for the description of human sequence variations. Hum Mutat 2000;15:7–12.
- Westermark P, Murphy C, Eulitz M, Wallgren-Pettersson C, Udd B, Hellman U, Ihse E, et al. Galectin 7-associated cutaneous amyloidosis. Amyloid 2010;17 (Suppl 1):71.
- Caubet C, Bousset L, Clemmensen O, Sourigues Y, Bygum A, Chavanas S, Coudane F, et al. A new amyloidosis caused by fibrillar aggregates of mutated corneodesmosin. FASEB J 2010;24:3416–3426.
- Willander H, Askarieh G, Landreh M, Westermark P, Nordling K, Keränen H, Hermansson E, et al. High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C. Proc Natl Acad Sci USA 2012;109:2325–2329.
- Münch J, Rücker E, Ständker L, Adermann K, Goffinet C, Schindler M, Wildum S, et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 2007;131:1059–1071.
- Gharibyan AL, Raveh D, Morozova-Roche LA. S100A8/A9 amyloidosis in the ageing prostate: relating ex vivo and in vitro studies. Methods Mol Biol 2012;849:387–401.
- Geisel O, Mentele R, Lottspeich F, Linke RP. Systemic amyloidosis of fibrinogen origin in the wild living stone marten (Martes foina); XIth Internat. In: Skinner M, Berk JL, Conners LH, Seldin DC, editors. Symposium on Amyloidosis. Boca Raton, FL, USA: CRC Press; 2007. pp 133–135.
- Nomenclature of amyloid and amyloidosis. WHO-IUIS Nomenclature Sub-Committee. Bull World Health Organ. 1973;71:105–112.
- Cohen AS, Franklin EC, Glenner, GG, Natvig JB, Osserman EF, Wegelius O. Nomenclature. In: Wegelius O, Pastenack A, editors. Amyloidosis. London: Academic Press; 1976. p ix.
- Benditt EP, Cohen AS, Costa PP, Franklin EC, Glenner GG, Husby G, Mandema E, et al. Guidelines for nomenclature. In: Glenner GG, Costa PP, Freitas AF, editors. Amyloid and Amyloidosis. Amsterdam: Excerpta Medica; 1980. pp XI–XII.
- Husby G, Araki S, Benditt EP, Benson MD, Cohen AS, Frangione B, Glenner GG, et al. The 1990 guidelines for nomenclature and classification of amyloid and amyloidosis. In: Natvig JB, Förre O, Husby G, Husebekk A, Skogen B, Sletten K, Westermark P, editors. Amyloid and Amyloidosis 1990. Dordrecht: Kluwer; 1991. pp 7–11.
- Westermark P. Classification of amyloid fibril proteins and their precursors: an ongoing discussion. Amyloid 1997;4:216–218.
- Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, Masters CL, et al. Amyloid fibril protein nomenclature – 2002. Amyloid 2002;9:197–200.
- Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, Masters CL, et al.; Nomenclature Committee of the International Society of Amyloidosis. Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid 2005;12:1–4.
- Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, Masters CL, et al. A primer of amyloid nomenclature. Amyloid 2007;14:179–183.
- Maury CP. The emerging concept of functional amyloid. J Intern Med 2009;265:329–334.
- Fowler DM, Koulov AV, Balch WE, Kelly JW. Functional amyloid–from bacteria to humans. Trends Biochem Sci 2007;32:217–224.
- Maji SK, Perrin MH, Sawaya MR, Jessberger S, Vadodaria K, Rissman RA, Singru PS, et al. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 2009;325:328–332.